Patents by Inventor Anne-Marie Virginie Renee Lambeir

Anne-Marie Virginie Renee Lambeir has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Urokinase inhibitors
    Patent number: 8003627
    Abstract: The present invention relates to novel compounds with inhibitory activity towards urokinase plasminogen activator (uPA); to methods for preparation of said uPA inhibitor compounds; to pharmaceutical compositions comprising said uPA inhibitor compounds; to the use of said uPA inhibitor compounds as a medicament and the use of said uPA inhibitor compounds for the preparation of a medicament for the treatment of conditions chosen from the group comprising cancer, tumour growth, tumour invasion, tumour metastasis, diabetic retinopathy, hemorrhagic atherosclerosis and inflammatory conditions, such as rheumatoid arthritis and psoriasis.
    Type: Grant
    Filed: October 20, 2006
    Date of Patent: August 23, 2011
    Assignee: Universiteit Antwerpen
    Inventors: Koen Augustyns, Jurgen Joossens, Pieter Van Der Veken, Anne-Marie Virginie Renée Lambeir, Simon Scharpé, Achiel Haemers
  • Novel Urokinase Inhibitors
    Publication number: 20080312191
    Abstract: The present invention relates to novel compounds with inhibitory activity towards urokinase plasminogen activator (uPA); to methods for preparation of said uPA inhibitor compounds; to pharmaceutical compositions comprising said uPA inhibitor compounds; to the use of said uPA inhibitor compounds as a medicament and the use of said uPA inhibitor compounds for the preparation of a medicament for the treatment of conditions chosen from the group comprising cancer, tumour growth, tumour invasion, tumour metastasis, diabetic retinopathy, hemorrhagic atherosclerosis and inflammatory conditions, such as rheumatoid arthritis and psoriasis.
    Type: Application
    Filed: October 20, 2006
    Publication date: December 18, 2008
    Applicant: UNIVERSITEIT ANTWERPEN
    Inventors: Koen Augustyns, Jurgen Joossens, Pieter Van Der Veken, Anne-Marie Virginie Renee Lambeir, Simon Scharpe, Achiel Haemers
  • Serine peptidase modulators
    Publication number: 20020061839
    Abstract: The present invention relates to new compounds having modulatory (inhibitory and stimulatory) activity on serine peptidases and proteases in general and dipeptidyl peptidase IV, prolyl oligopeptidase (PO), dipeptidyl peptidase II (DPP II), fibroblast activation protein &agr; (FAP&agr;), lysosomal Pro—X carboxypeptidase and elastase in particular. These new compounds can be used for the treatment of a variety of disease states in which these peptidases are involved.
    Type: Application
    Filed: April 18, 2001
    Publication date: May 23, 2002
    Inventors: Simon Lodewijk Scharpe, Ingrid Anna Jozef De Meester, Anne-Marie Virginie Renee Lambeir, Koen Jan Ludovicus Augustyns, Achiel Jean-Marie Haemers, Filip Jozef Anny Goossens, Dirk Frans Hendriks, Alexandre Arkadicvitch Beliaev
  • Serine proteases, their activity and their synthetic inhibitors
    Patent number: 6090786
    Abstract: The present invention relates to new compounds of the general formula: Z-Xaa-Y', in which Xaa is an amino acid, Z is a protecting group and Y' is one of various types of ring structures. The new compounds have a modulating activity on serine proteases. The invention further relates to the use of the compounds in therapy and diagnosis and to a method of purifying the serine protease DPPIV.
    Type: Grant
    Filed: February 19, 1997
    Date of Patent: July 18, 2000
    Assignee: FondaTech Benelux N.V.
    Inventors: Koen Jan Ludovicus Augustyns, Greta Constantia Vanhoof, Marianne Jean Frieda Borloo, Ingrid Anna Jozef De Meester, Filip Jozef Anny Goossens, Achiel Jean-Marie Haemers, Dirk Frans Hendriks, Anne-Marie Virginie Renee Lambeir, Simon Lodewijk Scharpe